Fig. 7.

Pathways involved in the pathogenesis of dystrophic muscle. An absence of dystrophin leads to the compensatory up-regulation of actin cytoskeletal signaling and ILK pathway activation to reduce contraction-induced injury in skeletal muscle. In parallel, reduced mitochondrial function, along with disturbances in calcium homeostasis, exacerbate the disease phenotype.